Kempnich has a leading role in medical research technology
Michael Kempnich is a 2009 Nevis High School graduate.
Stay updated with breaking news from Applied Cells. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Michael Kempnich is a 2009 Nevis High School graduate.
Wilmington, DE (PRWEB) December 16, 2022 -- Each year The Scientist highlights the latest and greatest tools, technologies, and techniques to hit the life
November 18th, 2022. Today, Applied Cells Inc. and GenScript USA Incorporated announced their strategic collaboration to deliver combined cell isolation solutions for cell therapy drug development worldwide. Under this collaboration, GenScript will develop and supply its proprietary research and cGMP grade CytoSinct™ reagents for use in developing CAR-T and other Cell Therapy products on the Applied Cells MARS® Platform.
/PRNewswire/ -- Today, Applied Cells Inc. and GenScript USA Incorporated announced their strategic collaboration to deliver combined cell isolation solutions...
/PRNewswire/ -- ThinkCyte Inc., a biotechnology company pioneering Ghost Cytometry, a proprietary AI-based, label-free cell sorting technology, today announced...